Record Information
Version1.0
Creation Date2019-07-14 16:55:46 UTC
Last Updated2019-10-01 21:42:23 UTC
CypComp IDCC02546
Compound Information
NameAlvameline
Structure ImageRnmomkcrcirycz uhfffaoysa n
InChIKeyRNMOMKCRCIRYCZ-UHFFFAOYSA-N
PubChem ID178030
CypCompound Information
SetCypBoM Testing Set
Bonds of Metabolism (BoMs)
CYP1A2CYP2A6CYP2B6CYP2C8CYP2C9CYP2C19CYP2D6CYP2E1CYP3A4
  • <11,1;Cleavage;R1>
  • <11,H;Oxidation;R1>
  • <1,N;N-Oxidation;R2>
  • <11,1;Cleavage;R1>
  • <11,H;Oxidation;R1>
  • Not Available
  • Not Available
  • Not Available
  • <11,1;Cleavage;R1>
  • <11,H;Oxidation;R1>
  • <1,N;N-Oxidation;R2>
  • <13,2;Cleavage;R1>
  • <13,H;Oxidation;R1>
  • Not Available
  • <11,1;Cleavage;R1>
  • <11,H;Oxidation;R1>
References
  1. Jensen KG, Dalgaard L: In vitro metabolism of the M1-muscarinic agonist 5-(2-ethyl-2H-tetrazol-5-yl)-1-methyl-1,2,3,6-tetrahydropyridine by human hepatic cytochromes P-450 determined at pH 7.4 and 8.5. Drug Metab Dispos. 1999 Jan;27(1):125-32. [PubMed:9884321 ]
Download FileCC02546.sdf